Multidistrict litigation (MDL) is a federal legal procedure that consolidates civil cases from courts across the country into a single federal district court when those cases share common factual issues. Congress created this mechanism in 1968 through statute 28 U.S.C. § 1407 to handle the growing complexity of mass litigation more efficiently. Rather than having hundreds or thousands of nearly identical lawsuits proceed separately in different courts””wasting judicial resources and risking contradictory rulings””MDL allows one judge to oversee all pretrial proceedings, including discovery and motions, before cases either settle or return to their original courts for trial.
The scale of MDL in the federal court system is substantial. As of January 2026, MDL comprises over 50 percent of the entire federal civil caseload, encompassing approximately 200,000 pending cases. To put this in perspective, the Johnson & Johnson talcum powder litigation alone has 67,580 pending actions consolidated before a single judge in New Jersey. This consolidation mechanism has become the primary tool for managing mass tort litigation involving defective products, pharmaceutical injuries, and corporate misconduct affecting thousands of people nationwide. This article examines how MDL works in practice, the role of the Judicial Panel on Multidistrict Litigation, how this procedure differs from class actions, and what plaintiffs should understand when their case becomes part of an MDL.
Table of Contents
- How Does Multidistrict Litigation Consolidate Federal Cases?
- The Role of the Judicial Panel on Multidistrict Litigation
- MDL vs. Class Action: Understanding the Key Differences
- How Bellwether Trials Shape MDL Outcomes
- What Plaintiffs Should Know Before Joining an MDL
- Current MDL Statistics and Case Distribution
- The Future of Multidistrict Litigation
- Conclusion
How Does Multidistrict Litigation Consolidate Federal Cases?
The MDL process begins when multiple lawsuits involving similar factual questions are filed in federal courts across the country. The U.S. Judicial Panel on Multidistrict Litigation””a specialized body of seven federal district court judges appointed by the Chief Justice of the United States””reviews whether consolidation would serve the convenience of the parties and witnesses while promoting the just and efficient conduct of the litigation. Either parties to the lawsuits or the Panel itself can initiate this transfer process. Once the JPML decides to consolidate cases, it selects a single transferee court and assigns the litigation to one district judge. This judge then supervises all pretrial activities, which typically constitute the most time-consuming and expensive phases of litigation: discovery (the exchange of evidence between parties), depositions, expert witness disputes, and dispositive motions. For example, when thousands of lawsuits alleged that certain hernia mesh products caused injuries, the JPML consolidated those cases into MDL-2846 before Judge Edmund A.
Sargus, Jr. in Ohio, where 23,749 actions are currently pending. However, consolidation has important limits. MDL only covers pretrial proceedings. If cases are not resolved through settlement or summary judgment, they must be remanded””sent back””to their original district courts for trial. This means a plaintiff who filed in California will ultimately have their trial in California, even though pretrial work occurred in Ohio or New Jersey. This distinction preserves plaintiffs’ venue rights while still capturing the efficiency benefits of consolidated pretrial management.
The Role of the Judicial Panel on Multidistrict Litigation
The JPML serves as the gatekeeper for federal multidistrict litigation. This seven-judge panel evaluates petitions for consolidation, decides which cases qualify for MDL treatment, and selects both the transferee district and the specific judge who will manage the consolidated proceedings. The panel’s decisions are based on whether common questions of fact exist and whether transfer would promote efficiency without unduly burdening any party. Selecting the right transferee court involves multiple considerations. The panel examines where the most cases are pending, the location of relevant evidence and witnesses, the experience of potential transferee judges with complex litigation, and the court’s capacity to handle a large docket.
For the aqueous film-forming foams products liability litigation””involving firefighting foam contamination of water supplies””the JPML assigned the 15,213 pending cases to Judge Richard M. Gergel in South Carolina, creating MDL-2873. One limitation worth noting: the JPML’s transfer decisions are essentially unreviewable. Appellate courts have minimal authority to second-guess these determinations, which means parties generally must accept the panel’s choice of venue and judge. While this streamlines the process, it also means plaintiffs have limited recourse if they believe the selected forum is inconvenient or the assigned judge is unsuitable for their particular claims.
MDL vs. Class Action: Understanding the Key Differences
The distinction between MDL and class action lawsuits causes frequent confusion, but understanding it matters for anyone whose case might fall into either category. In a class action, individual plaintiffs are formally joined into a single legal action””one lawsuit represents everyone, and decisions bind all class members unless they opt out. In contrast, MDL keeps each plaintiff’s case legally separate while grouping them together only for pretrial efficiency. This structural difference has significant practical implications. Class action plaintiffs share a single outcome determined by class-wide proceedings, and their individual circumstances may receive limited attention.
MDL plaintiffs retain their individual attorneys, maintain their own damage claims, and preserve the right to their own trial if the case doesn’t settle. For instance, one plaintiff’s talcum powder injury may have caused ovarian cancer while another’s may have caused mesothelioma””the MDL allows both cases to share discovery about the defendant’s conduct while preserving each plaintiff’s distinct medical and damage claims. The tradeoff involves control and compensation. Class actions provide less individual attention but can deliver faster, more uniform resolutions. MDL preserves individual case characteristics but can result in cases languishing for years in a massive consolidated docket. Products liability cases””which constitute only 32.9 percent of all MDLs but account for 91 percent of total civil cases within MDLs””tend to favor the MDL structure because individual plaintiffs have varying injuries and damages that don’t fit neatly into class-wide treatment.
How Bellwether Trials Shape MDL Outcomes
Because transferring thousands of cases back to their home courts for individual trials would undermine MDL efficiency, courts have developed bellwether trials as a practical solution. Bellwether trials select a small number of representative cases to proceed to trial within the MDL court, providing data points about how juries evaluate the evidence, assess credibility, and determine damages. The bellwether process typically works like this: the parties and the court select cases that represent the range of claims in the MDL””perhaps some with strong facts for plaintiffs, some favoring defendants, and some in between. These cases proceed through trial while the remaining cases wait. The outcomes inform settlement negotiations by showing both sides what they can expect if they litigate.
A plaintiff verdict with substantial damages creates settlement pressure on defendants; defense verdicts strengthen defendants’ negotiating position. However, bellwether trials have limitations. Critics argue that parties can strategically select cases that skew results””plaintiffs might push for trials of their strongest cases, while defendants prefer weaker ones. Additionally, bellwether verdicts aren’t binding on other cases in the MDL; they’re informational, not precedential. A defendant who loses three bellwether trials can still refuse to settle the remaining cases, potentially forcing thousands of remands for individual trials. This happened in some opioid-related litigation, where bellwether results didn’t produce comprehensive settlements.
What Plaintiffs Should Know Before Joining an MDL
When your case becomes part of an MDL, several practical realities merit attention. First, you retain your own attorney even though lead counsel will coordinate pretrial activities. The MDL court typically appoints a Plaintiffs’ Steering Committee””a group of experienced attorneys who manage discovery, brief common legal issues, and negotiate with defendants on behalf of all plaintiffs. Your individual attorney works within this structure but still advocates for your specific interests. The timeline for MDL resolution varies dramatically and often extends for years. The largest MDLs involve defendants with substantial resources to litigate aggressively.
Johnson & Johnson’s talcum powder MDL has been pending since 2016, and despite tens of thousands of cases and multiple bellwether trials, comprehensive resolution remains elusive. Plaintiffs should understand that entering an MDL likely means a long wait, even if the consolidation ultimately produces a more favorable outcome than individual litigation would have. Settlement dynamics in MDL also differ from ordinary litigation. Mass settlements often create “inventory” arrangements where plaintiffs’ attorneys agree to recommend settlement to all their clients in exchange for aggregate payments. While these arrangements can efficiently resolve thousands of cases, they sometimes pressure individual plaintiffs to accept offers that may not fully reflect their particular damages. Plaintiffs should discuss their attorney’s approach to MDL settlements and understand what individual evaluation their case will receive.
Current MDL Statistics and Case Distribution
The numbers behind MDL reveal its dominance in federal civil litigation. By the end of 2018, 51.9 percent of all pending federal civil cases””156,511 out of 301,766 total cases””had been centralized into 248 separate MDLs. That percentage has only grown, with current estimates placing MDL at over 50 percent of the federal civil caseload with approximately 200,000 pending cases.
Products liability cases drive these numbers. While product liability matters represent only 32.9 percent of MDL dockets by count, they contain 91 percent of the actual cases consolidated in MDL. The remaining MDLs divide among antitrust (24.1 percent of MDL dockets), sales practices (12.1 percent), and other case types. This concentration means a handful of mass tort MDLs””pharmaceutical injuries, medical devices, and consumer products””account for the vast majority of consolidated federal litigation.
The Future of Multidistrict Litigation
MDL has evolved substantially since Congress enacted it in 1968 to handle antitrust cases arising from the electrical equipment industry. Today’s MDLs are larger, last longer, and involve more complex coordination challenges than the procedure’s creators anticipated. Federal courts continue adapting, with increased attention to plaintiff vetting (ensuring consolidated cases have legitimate claims), case management protocols for mega-MDLs, and procedures for handling litigation funding arrangements.
Reform discussions focus on efficiency and fairness tensions. Some proposals would allow MDL courts to conduct trials rather than remanding cases, eliminating the fiction that consolidated cases will actually return home for individual adjudication. Others emphasize strengthening individual plaintiff protections within mass settlement frameworks. As MDL continues handling the majority of federal civil litigation, these procedural questions will shape how mass injuries receive judicial attention for decades to come.
Conclusion
Multidistrict litigation represents the federal court system’s primary mechanism for managing mass litigation efficiently. By consolidating cases with common factual issues before a single judge for pretrial proceedings, MDL conserves judicial resources, promotes consistent rulings, and creates settlement incentives that can resolve thousands of claims. The procedure has grown to encompass over half of all federal civil cases, with products liability matters dominating the MDL landscape.
For plaintiffs whose cases enter an MDL, understanding the process helps set realistic expectations. You retain your individual attorney and your separate case, but your litigation timeline will be governed by a larger coordinated effort. Bellwether trials may test how juries respond to cases like yours, and settlement negotiations will likely occur at a mass level. Whether you’re considering filing a claim that might join an MDL or already have a case consolidated into one, recognizing how this federal procedure works provides essential context for the legal process ahead.